Accuray creates joint venture in China

By staff writers

January 29, 2019 -- Radiation oncology firm Accuray's Asian subsidiary has formed a joint venture with CNNC High Energy Equipment of Tianjin, China, to manufacture and sell radiation oncology systems in China.

CNNC, a subsidiary of China Isotope and Radiation (CIRC), will own 51% of the venture, with Accuray Asia owning the remaining 49% of the entity, which will be known as CNNC Accuray and will be located in Tianjin. Sales operations are expected to begin toward the end of the 2019 calendar year.

The two companies said the venture will help meet short- and long-term market demand and healthcare needs as stipulated by the Ministry of Health of the People's Republic of China.

Copyright © 2019

To read this and get access to all of the exclusive content on create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking